Hardwick Medical Ltd 8964067 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Genereal medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 8964067 2023-04-01 2024-03-31 8964067 2024-03-31 8964067 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 8964067 core:FurnitureFittingsToolsEquipment 2024-03-31 8964067 bus:SmallEntities 2023-04-01 2024-03-31 8964067 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 8964067 bus:FilletedAccounts 2023-04-01 2024-03-31 8964067 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 8964067 bus:RegisteredOffice 2023-04-01 2024-03-31 8964067 bus:CompanySecretaryDirector1 2023-04-01 2024-03-31 8964067 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 8964067 core:FurnitureFittings 2023-04-01 2024-03-31 8964067 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 8964067 core:OfficeEquipment 2023-04-01 2024-03-31 8964067 countries:England 2023-04-01 2024-03-31 8964067 2023-03-31 8964067 core:FurnitureFittingsToolsEquipment 2023-03-31 8964067 2022-04-01 2023-03-31 8964067 2023-03-31 8964067 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 8964067 core:FurnitureFittingsToolsEquipment 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 8964067

Hardwick Medical Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

Hardwick Medical Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

Hardwick Medical Ltd

Company Information

Director

Dr Gareth Hull

Company secretary

Dr Gareth Hull

Registered office

Hollymount House
Pepsy Road
SW20 8NP

Accountants

Charles Rippin & Turner
Chartered Accountants
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

 

Hardwick Medical Ltd

(Registration number: 8964067)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

177,383

170,684

Current assets

 

Cash at bank and in hand

 

1,526

8,954

Creditors: Amounts falling due within one year

(1,248)

(984)

Net current assets

 

278

7,970

Total assets less current liabilities

 

177,661

178,654

Accruals and deferred income

 

(4,000)

(4,045)

Net assets

 

173,661

174,609

Capital and reserves

 

Called up share capital

3

3

Retained earnings

173,658

174,606

Shareholders' funds

 

173,661

174,609

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 29 June 2024
 

.........................................
Dr Gareth Hull
Company secretary and director

 

Hardwick Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Hollymount House
Pepsy Road
SW20 8NP
England

These financial statements were authorised for issue by the director on 29 June 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

Hardwick Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Asset class

Depreciation method and rate

Fixtures and fittings

reducing balance - 20% per annum

Office equipment

reducing balance - 20% per annum

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

 

Hardwick Medical Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2023

188,871

188,871

Additions

23,000

23,000

Disposals

(18,000)

(18,000)

At 31 March 2024

193,871

193,871

Depreciation

At 1 April 2023

18,187

18,187

Charge for the year

16,301

16,301

Eliminated on disposal

(18,000)

(18,000)

At 31 March 2024

16,488

16,488

Carrying amount

At 31 March 2024

177,383

177,383

At 31 March 2023

170,684

170,684